SCHEMBL2325537

SCHEMBL2325537

CCCCCCCCCCCCCCCCN(C)CC

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 3/20 0.60
S1PR2 O95136 1/20 0.50
S1PR1 P21453 1/20 0.50
S1PR3 Q99500 1/20 0.50
S1PR5 Q9H228 1/20 0.50
TSHR P16473 2/20 0.47
THRB P10828 1/20 0.47
GGPS1 O95749 4/20 0.47
CHRM2 P08172 1/20 0.43
MGLL Q99685 1/20 0.41
KDM5A P29375 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
PHF8 Q9UPP1 1/20 0.41
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA9 Q16790 1/20 0.41
FDPS P14324 1/20 0.41
AGTR1 P30556 1/20 0.41
OPRM1 P35372 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21558 1.00 DNM1 (0.60) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL5440531 1.00 DNM1 (0.60) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL15966132 1.00 DNM1 (0.60) DNM1S1PR2S1PR1S1PR3S1PR5
Octane SCHEMBL639592 1.00 DNM1 (0.60) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL5450820 1.00 DNM1 (0.60) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL669422 1.00 DNM1 (0.60) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL5450695 1.00 DNM1 (0.60) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL5439333 1.00 DNM1 (0.60) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL2129520 1.00 DNM1 (0.60) DNM1S1PR2S1PR1S1PR3S1PR5
SCHEMBL613171 1.00 DNM1 (0.60) DNM1S1PR2S1PR1S1PR3S1PR5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 131 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105814017-B The oxidation of 2 mercapto ethanol 巴斯夫欧洲公司 2019-02-12 CN claimed
EP-3080079-B1 OXIDATION OF 2-MERCAPTOETHANOL BASF SE (DE) 2018-07-25 EP claimed
US-20160318860-A1 OXIDATION OF 2-MERCAPTOETHANOL BASF SE (DE) 2016-11-03 US claimed
EP-3080079-A1 OXIDATION OF 2-MERCAPTOETHANOL BASF SE (DE) 2016-10-19 EP claimed
WO-2015086565-A1 OXIDATION OF 2-MERCAPTOETHANOL BASF SE (DE) 2015-06-18 WO claimed
EP-1904898-B1 METHOD FOR FINE LINE RESIST STRIPPING ATOTECH DEUTSCHLAND GMBH (DE) 2011-08-17 EP claimed
CN-101185034-A Method for fine line resist stripping ATOTECH DEUTSCHLAND GMBH (DE) 2008-05-21 CN claimed
EP-1904898-A1 METHOD FOR FINE LINE RESIST STRIPPING ATOTECH DEUTSCHLAND GMBH (DE) 2008-04-02 EP claimed
WO-2006128642-A1 METHOD FOR FINE LINE RESIST STRIPPING ATOTECH DEUTSCHLAND GMBH (DE) 2006-12-07 WO claimed
EP-1729179-A1 Method for fine line resist stripping ATOTECH DEUTSCHLAND GMBH (DE) 2006-12-06 EP claimed
US-4410697-A CARBAMATE, AMINE, TERTIARY AMINE CATALYST REANAL FINOMVEGYSZERGYAR (HU) 1983-10-18 US claimed
CN-116323712-B Alkali releasing composition and curable resin composition using same 纳美仕有限公司 2024-09-03 CN disclosed
US-20240207178-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2024-06-27 US disclosed
EP-3538575-B1 HIGH CIS-1,4 BLOCK COPOLYMERS OF POLYBUTADIENE AND POLYISOPRENE BRIDGESTONE CORP (JP) 2024-03-13 EP disclosed
WO-2024044481-A1 POLYOLEFIN ELASTOMER VITRIMER PREPARED WITH MULTI-FUNCTIONAL BORON-ESTER CROSSLINKERS EXXONMOBIL CHEMICAL PATENTS INC. (US) 2024-02-29 WO disclosed
US-5103053-A Process for treating tert-amines ETHYL CORPORATION (US) 1992-04-07 US disclosed
US-5103052-A Tertiary amine treatment ETHYL CORPORATION (US) 1992-04-07 US disclosed
US-5102777-A Immersion solution consists of a solvent, amine and fatty acid , corrosion and chemical resistance to underlying metal layer ARDROX INC. (US) 1992-04-07 US disclosed
EP-0442638-A2 Polymeric compounds Du Pont (UK) Limited (GB) 1991-08-21 EP disclosed
EP-0358400-A2 Improvements in or relating to polymeric compounds E.I. DU PONT DE NEMOURS AND COMPANY (US) 1990-03-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160318860-A1 OXIDATION OF 2-MERCAPTOETHANOL HAO2, GPX4, SQOR DNM1 2773/4885S1PR2 1936/4885S1PR1 2700/4885
US-20240207178-A1 COMPOSITIONS AND METHODS FOR TARGETED DELIVERY TO CELLS CHMP4B, LIPA, NPC1L1 DNM1 307/4885S1PR2 677/4885S1PR1 595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.